Out of stock

This item is currently unavailable

Gone for 75 days. Could come back at any time — we're watching for you.

Out of stock 75 days

World Outlook for Cystic Fibrosis Therapeutics 2025-2030

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

View at Amazon ↗
Out of stock

Price data last checked 75 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

No price data available for histogram

Description

This comprehensive study provides a global outlook for cystic fibrosis therapeutics from 2025 through 2030. Covering more than 190 countries, the report utilizes econometric models to project fundamental economic dynamics within and across nations. Readers gain access to detailed estimates for latent demand, also referred to as potential industry earnings (P.I.E.), measured in millions of U.S. dollars for each reported year. The data includes the percent share each country holds within its specific region and its share of the global market. These comparative benchmarks enable users to quickly evaluate specific countries against others in the industry. This resource is designed for professional analysis of the global cystic fibrosis therapeutic landscape.

Key Features

Provides a global outlook for cystic fibrosis therapeutics covering more than 190 countries.

Includes latent demand estimates, known as potential industry earnings (P.I.E.), in millions of U.S. dollars.

Offers comparative benchmarks by showing the percent share of each country relative to its region and the globe.

Uses econometric models to project fundamental economic dynamics for each country and across different nations.

Covers a multi-year forecast period spanning from 2025 to 2030.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
28 April 2024

Similar Products You Might Like

World Outlook for Cystic Fibrosis Drugs 2025-2030 Report
99% match

World Outlook for Cystic Fibrosis Drugs 2025-2030 Report

Price unavailable
The 2011-2016 Outlook for Cystic Fibrosis Drugs in Asia & Oceana
98% match

The 2011-2016 Outlook for Cystic Fibrosis Drugs in Asia & Oceana

£325.00 11 Sep 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India
97% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India

£515.00 02 Sep 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India
97% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India

£515.00 02 Sep 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China
97% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China

£495.00 28 Aug 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments for US Zip Codes
96% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments for US Zip Codes

£490.00 27 Aug 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in Japan
96% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in Japan

£495.00 02 Sep 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in Japan
96% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in Japan

£495.00 02 Sep 2026
Cystic Fibrosis: Facts, Management and Advances
96% match

Cystic Fibrosis: Facts, Management and Advances

IntechOpen

£118.98 24 Sep 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments for US Zip Codes
96% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments for US Zip Codes

£490.00 28 Aug 2026
Cystic Fibrosis: Heterogeneity and Personalized Treatment
96% match

Cystic Fibrosis: Heterogeneity and Personalized Treatment

IntechOpen

£114.00 25 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States

£520.00 02 Oct 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India
95% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India

£515.00 01 Oct 2026
Congenital Cystic Lung Disease: Comprehensive Understanding of its Diagnosis and Treatment from Fetus to Childhood
95% match

Congenital Cystic Lung Disease: Comprehensive Understanding of its Diagnosis and Treatment from Fetus to Childhood

Springer

£65.61 23 Sep 2026
COPD Treatment Outlook 2023-2028 - US Zip Code Analysis
95% match

COPD Treatment Outlook 2023-2028 - US Zip Code Analysis

£490.00 02 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
95% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
95% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026